Patents Assigned to Prodigene
  • Patent number: 8685405
    Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.
    Type: Grant
    Filed: March 14, 2012
    Date of Patent: April 1, 2014
    Assignees: ProdiGene, Inc., Novartis AG
    Inventors: Linda Bootland, Katherine Beifuss
  • Patent number: 8158855
    Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: April 17, 2012
    Assignees: ProdiGene, Inc., Novartis A.G.
    Inventors: Linda Bootland, Katherine Beifuss
  • Patent number: 7985891
    Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: July 26, 2011
    Assignees: ProdiGene, Inc., Novartis AG
    Inventors: Linda Bootland, Katherine Beifuss
  • Publication number: 20090280136
    Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.
    Type: Application
    Filed: November 15, 2007
    Publication date: November 12, 2009
    Applicants: ProdiGene, Inc., Novartis AG
    Inventors: Linda Bootland, Katherine Beifuss
  • Publication number: 20090249519
    Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.
    Type: Application
    Filed: November 15, 2007
    Publication date: October 1, 2009
    Applicants: ProdiGene, Inc., Novartis AG
    Inventors: Linda Bootland, Katherine Beifuss
  • Patent number: 7541515
    Abstract: Increased expression of heterologous proteins in a plant is achieved by introducing the nucleotide sequence encoding the heterologous protein into a plant that has high oil seed content compared to low oil seed and/or is introduced into a plant having reduced alcohol soluble proteins in the endosperm. The nucleotide sequence may be introduced by direct transformation into the plant, or by direct transformation into another plant, and crossing with the high oil plant or plant have reduced levels of alcohol soluble protein in the endosperm. Further, the nucleotide sequences may be introduced into one or both of the high oil plant and the plant having reduced levels of alcohol soluble proteins, and the plants may be crossed to result in a progeny having even further increased expression levels of the heterologous protein.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: June 2, 2009
    Assignee: ProdiGene, Inc.
    Inventors: Elizabeth Hood, John Howard, Donna Delaney
  • Patent number: 7504560
    Abstract: The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion of those plants. A DNA sequence encoding for the expression of a surface antigen of a viral pathogen is isolated and ligated to a promoter which can regulate the production of the surface antigen in a transgenic plant. This gene is then transferred to plant cells using a procedure that results in its integration into the plant genome, such as through the use of an Agrobacterium tumenfaciens plasmid vector system. Preferably, the foreign gene is expressed in an portion of the plant that is edible by humans or animals. In a preferred procedure, the vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.
    Type: Grant
    Filed: May 12, 2005
    Date of Patent: March 17, 2009
    Assignee: Prodigene, Inc.
    Inventors: Charles Joel Arntzen, Dominic Man-Kit Lam
  • Patent number: 7393998
    Abstract: Plants are engineered to express proinsulin or insulin. The plants can be used as a source of the protein for a variety of purposes. Plant tissue can be orally administered to animals to replace the necessity of injection of insulin. Alternatively, the protein can be extracted from plant tissue and delivered to animals. Plant produced proteins can also provide a less expensive and more readily available source of the protein as reagents or in other experimentation involving insulin proteins.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: July 1, 2008
    Assignee: ProdiGene, Inc.
    Inventors: Stephen Streatfiled, John Howard
  • Publication number: 20060015971
    Abstract: Production of proteases in plants is set forth, whereby heterologous DNA encoding the protease is introduced into the plant and expression of the protein achieved. By such methods, expression is achieved in plants wherein the plant cell is not damaged, the protein can be recovered without contamination by other proteases, and can be expressed at levels such that commercial production of the enzyme is obtained. Expression levels can be at 0.1% of total soluble protein of the plant, or higher.
    Type: Application
    Filed: September 14, 2005
    Publication date: January 19, 2006
    Applicant: ProdiGene, Inc.
    Inventors: John Howard, Elizabeth Hood
  • Publication number: 20040250298
    Abstract: The present invention provides novel methods for determining whether a cell has incorporated a polynucleotide comprising the use of organophosphate hydrolase activity as a marker which has both selectable and screenable properties.
    Type: Application
    Filed: December 3, 2003
    Publication date: December 9, 2004
    Applicant: ProdiGene, Inc.
    Inventors: T. Scott Pinkerton, John A. Howard, James R. Wild
  • Patent number: 6800792
    Abstract: Expression of laccase in plants at commercial levels of production is provided. The laccase gene is preferably operably linked with promoter sequences preferentially directing expression of laccase to the seed of the plant, and may additionally include sequences directing expression to the plant cell wall. Methods of improving the process of introducing DNA into plants via Agrobacterium are also provided.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: October 5, 2004
    Assignees: ProdiGene Inc., Genencor International, Inc.
    Inventors: John A. Howard, Elizabeth Hood, Joseph Jilka
  • Publication number: 20030200566
    Abstract: Plants are engineered to express proinsulin or insulin. The plants can be used as a source of the protein for a variety of purposes. Plant tissue can be orally administered to animals to replace the necessity of injection of insulin. Alternatively, the protein can be extracted from plant tissue and delivered to animals. Plant produced proteins can also provide a less expensive and more readily available source of the protein as reagents or in other experimentation involving insulin proteins.
    Type: Application
    Filed: March 7, 2003
    Publication date: October 23, 2003
    Applicant: ProdiGene, Inc.
    Inventors: Stephen Streatfield, John Howard
  • Patent number: 6632930
    Abstract: A method of increasing recovery of active enzyme produced in a plant is provided where the enzyme requires a transitional metal cofactor for activation. The metal cofactor is supplied to the enzyme during plant development, during extraction, or after extraction. Recovery of active enzyme is also provided by incubating the extracted enzyme at a non-enzyme degrading temperature. Addition of a negative ion salt further improves active enzyme recovery. Optimum salt concentrations for recovery of laccase from plants using copper solutions is provided.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: October 14, 2003
    Assignees: Prodigene, Inc., Genencor International Inc.
    Inventors: Elizabeth Hood, John A. Howard, Michele Bailey, Franciscus J. C. van Gastel, Michael Ward, Huaming Wang, Susan Woodard
  • Publication number: 20030172406
    Abstract: A method of improving seed set of transgenic maize plants and improving agronomic characteristics of such plants is disclosed which employs the use of maize host cells that are the result of a cross between one parent that is Stiff Stalk derived germplasm and a second parent that is from the HiII genotype.
    Type: Application
    Filed: January 22, 2003
    Publication date: September 11, 2003
    Applicant: Prodigene, Inc.
    Inventor: Michael E. Horn
  • Publication number: 20030172409
    Abstract: A method of improving seed set of transgenic maize plants and improving agronomic characteristics of such plants is disclosed which employs the use of maize host cells that are the result of a cross between one parent that is Stiff Stalk derived germplasm and a second parent that is from the HiII genotype.
    Type: Application
    Filed: January 22, 2003
    Publication date: September 11, 2003
    Applicant: Prodigene, Inc.
    Inventor: Michael E. Horn
  • Publication number: 20030066108
    Abstract: The invention discloses novel promoter sequences capable of expressing genes in plant cells. The promoters include engineered versions of the maize ubiquitin promoter to increase expression levels beyond those observed with the native ubiquitin promoter and alter the tissue preference. Expression constructs, vectors, transgenic plants and methods are also disclosed.
    Type: Application
    Filed: February 28, 2002
    Publication date: April 3, 2003
    Applicant: Prodigene
    Inventors: Joseph M. Jilka, Elizabeth E. Hood, John A. Howard
  • Patent number: 6504085
    Abstract: A method for extraction of heterologous protein from plant seed comprises extracting the germ portion of the seed and extracting and purifying the protein from the germ. Enhanced expression in the germ is provided, and allows for improved efficiency in production, and cost savings. Directing expression to the germ portion further increases expression levels of the protein. The ubiquitin promoter preferentially directs expression to the germ portion of plant seed.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: January 7, 2003
    Assignee: ProdiGene, Inc.
    Inventor: John A. Howard
  • Patent number: 6136320
    Abstract: The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion of those plants. A DNA sequence encoding for the expression of a surface antigen of a viral pathogen is isolated and ligated to a promoter which can regulate the production of the surface antigen in a transgenic plant. This gene is then transferred to plant cells using a procedure that results in its integration into the plant genome, such as through the use of an Agrobacterium tumenfaciens plasmid vector system. Preferably, the foreign gene is expressed in an portion of the plant that is edible by humans or animals. In a preferred procedure, the vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.
    Type: Grant
    Filed: July 7, 1998
    Date of Patent: October 24, 2000
    Assignee: Prodigene, Inc.
    Inventors: Charles Joel Arntzen, Dominic Man-Kit Lam
  • Patent number: 6087558
    Abstract: Production of proteases in plants is set forth, whereby heterologous DNA encoding the protease is introduced into the plant and expression of the protein achieved. By such methods, expression is achieved in plants wherein the plant cell is not damaged, the protein can be recovered without contamination by other proteases, and can be expressed at levels such that commercial production of the enzyme is obtained. Expression levels can be at 0.1% of total soluble protein of the plant, or higher.
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: July 11, 2000
    Assignee: ProdiGene, Inc.
    Inventors: John A. Howard, Elizabeth Hood
  • Patent number: 6034298
    Abstract: The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion of those plants. A DNA sequence encoding for the expression of a surface antigen of a viral pathogen is isolated and ligated to a promoter which can regulate the production of the surface antigen in a transgenic plant. This gene is then transferred to plant cells using a procedure that results in its integration into the plant genome, such as through the use of an Agrobacterium tumefaciens plasmid vector system. Preferably, the foreign gene is expressed in a portion of the plant that is edible by humans or animals. In a preferred procedure, the vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: March 7, 2000
    Assignee: Prodigene, Inc.
    Inventors: Dominic Man-Kit Lam, Charles Joel Arntzen, Hugh Stanley Mason